Subscribe for Healthcare News, Simplified.
In this episode of Compliance Conversations, our host CJ Wolf, MD., sits down with Amy Brown
Do you love CIAs? If you’re a compliance professional, the answer is probably an enthusiastic, “Yes!”
The OIG has stated that entities “should regularly review the implementation and execution
I recently sat down with my fellow compliance professional and friend, Brian Burton,
“Three generic pharmaceutical manufacturers, Taro Pharmaceuticals USA, Inc., Sandoz Inc., and Apotex Corporation
HHS OCR tracks and publicly reports the top five issues in their investigated cases closed with corrective action.
It’s not every day that you get to meet your hero.
Hello folks! Many new items were added to the OIG’s Work Plan in March.